01 1Teva Pharmaceutical Industries
01 1ATENOLOL
01 1Israel
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2013-01-11
Pay. Date : 2012-11-13
DMF Number : 6213
Submission : 1986-03-05
Status : Active
Type : II
20
Teva Pharmaceutical Industries Ltd, based in Israel, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is ATENOLOL, with a corresponding US DMF Number 6213.
Remarkably, this DMF maintains an Active status since its submission on March 05, 1986, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of January 11, 2013, and payment made on November 13, 2012, indicating their dedication to facilitating drug approvals, Categorized as Type II
